Delivery Order SPE2DB22D1103-SPE2DB24FTFK8
- Not listed
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract worth $7,322.67 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of IMBRUVICA 420 MG TABLET 28S. This contract has a completion date of March 14, 2024 and was awarded on February 22, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and has previously received numerous federal contract awards from the Defense...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide IMBRUVICA 280 MG TABLET 28S. The contract has a potential value of $7,322.67 and a completion date of March 4, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of up to $999,999,999.00 and a performance period...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of IMBRUVICA 420 MG TABLET 28S. This $7,322.67 award has a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors noted. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds an indefinite delivery...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of IMBRUVICA 420 MG TABLET 28S. The contract has a potential value of $73,226.70 and a completion date of February 15, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor. This award is part of a larger indefinite delivery contract (IDC) between...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IMBRUVICA 420 MG TABLET 28S. The $21,968.01 contract has a performance period through January 25, 2024 and was awarded on January 3, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is an experienced prime contractor providing pharmaceutical products and related distribution services to support...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of IMBRUVICA 280 MG TABLET 28S. The $7,322.67 contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has previously provided a range of pharmaceutical products and medical supplies to DLA Troop Support Medical to support military treatment programs and...
- The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $7,322.67 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to military...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract, valued at $7,845.72, is for the delivery of Imbruvica 140 mg capsules over a period ending on March 20, 2024. AmerisourceBergen Drug Corp, as the prime contractor, will supply this pharmaceutical product to support military treatment programs and facilities....
- Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a $7,322.67 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide IMBRUVICA 420 MG TABLET 28S. This order is a part of Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The IDC, which does not have a set-aside designation,...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of IMBRUVICA 420 mg tablet in quantities of 28. The contract has a completion date of February 29, 2024 and a potential value of $7,322.67. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which does not have a set-aside designation. This delivery order...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTFK8Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IMBRUVICA 280 MG TABLET 28S, a pharmaceutical product, with a potential value of $7,322.67. The order has a completion date of March 11, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and has received numerous federal contract awards from DLA Troop Support Medical to supply pharmaceuticals and medical supplies in support of military treatment programs and facilities. This order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 2/16/24 |